Free Trial

BioAtla (BCAB) Insider Trading & Ownership

BioAtla logo
$1.56 -0.15 (-8.77%)
(As of 11/15/2024 ET)

BioAtla (NASDAQ:BCAB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.50%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$157,320.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get BCAB Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioAtla stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BCAB Insider Buying and Selling by Quarter

BioAtla Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/26/2023Sylvia McbrinnDirectorBuy4,000$2.33$9,320.00  
12/20/2023Jay M Phd ShortCEOBuy50,000$2.14$107,000.00  
12/19/2023Lawrence SteinmanDirectorBuy20,000$2.05$41,000.00  
(Data available from 1/1/2013 forward)

BCAB Insider Trading Activity - Frequently Asked Questions

11.50% of BioAtla stock is owned by insiders. Learn more on BCAB's insider holdings.

The following insiders have purchased BCAB shares in the last 24 months: Christian Vasquez ($48,000.00), Jay M Phd Short ($207,776.00), Lawrence Steinman ($41,000.00), and Sylvia Mcbrinn ($61,761.00).

Insiders have purchased a total of 142,500 BCAB shares in the last 24 months for a total of $358,537.00 bought.

BioAtla Key Executives



This page (NASDAQ:BCAB) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners